Published in Appl Environ Microbiol on January 01, 1995
A novel insertion element from Mycobacterium avium, IS1245, is a specific target for analysis of strain relatedness. J Clin Microbiol (1995) 3.20
Mycobacterium avium in the postgenomic era. Clin Microbiol Rev (2007) 2.65
IS1245 restriction fragment length polymorphism typing of Mycobacterium avium isolates: proposal for standardization. J Clin Microbiol (1998) 1.80
Sequencing of hsp65 distinguishes among subsets of the Mycobacterium avium complex. J Clin Microbiol (2006) 1.47
Relationship between IS901 in the Mycobacterium avium complex strains isolated from birds, animals, humans, and the environment and virulence for poultry. Clin Diagn Lab Immunol (2000) 1.41
Prevalence of Mycobacterium avium in slaughter pigs in The Netherlands and comparison of IS1245 restriction fragment length polymorphism patterns of porcine and human isolates. J Clin Microbiol (1999) 1.33
Species identification of Mycobacterium avium complex isolates by a variety of molecular techniques. J Clin Microbiol (2000) 1.24
Characterization of IS1245 for strain typing of Mycobacterium avium. J Clin Microbiol (1998) 1.17
Distribution of IS1311 and IS1245 in Mycobacterium avium subspecies revisited. J Clin Microbiol (2005) 1.15
Lymphadenitis in children is caused by Mycobacterium avium hominissuis and not related to 'bird tuberculosis'. Eur J Clin Microbiol Infect Dis (2008) 1.08
Typing of clinical Mycobacterium avium complex strains cultured during a 2-year period in Denmark by using IS1245. J Clin Microbiol (1999) 1.07
New probes used for IS1245 and IS1311 restriction fragment length polymorphism of Mycobacterium avium subsp. avium and Mycobacterium avium subsp. hominissuis isolates of human and animal origin in Norway. BMC Microbiol (2007) 1.01
PCR-restriction enzyme analysis of a bone marrow isolate from a human immunodeficiency virus-positive patient discloses polyclonal infection with two Mycobacterium avium strains. J Clin Microbiol (2000) 0.93
Characterization to species level of Mycobacterium avium complex strains from human immunodeficiency virus-positive and -negative patients. J Clin Microbiol (1997) 0.93
Molecular analysis of Mycobacterium avium isolates by using pulsed-field gel electrophoresis and PCR. J Clin Microbiol (1999) 0.89
IS1311 and IS1245 restriction fragment length polymorphism analyses, serotypes, and drug susceptibilities of Mycobacterium avium complex isolates obtained from a human immunodeficiency virus-negative patient. J Clin Microbiol (2002) 0.89
Typing of human Mycobacterium avium isolates in Italy by IS1245-based restriction fragment length polymorphism analysis. J Clin Microbiol (1998) 0.81
Prevalence of tuberculosis in pigs slaughtered at two abattoirs in Ethiopia and molecular characterization of Mycobacterium tuberculosis isolated from tuberculous-like lesions in pigs. BMC Vet Res (2013) 0.76
Genetic characterization of Mycobacterium avium isolates recovered from humans and animals in Australia. Epidemiol Infect (1996) 0.75
Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol (1993) 18.91
Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis (1979) 16.46
Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med (1991) 8.70
Sequence and characteristics of IS900, an insertion element identified in a human Crohn's disease isolate of Mycobacterium paratuberculosis. Nucleic Acids Res (1989) 6.92
Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS. Lancet (1994) 6.47
Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med (1989) 5.79
Molecular approach to identifying route of transmission of tuberculosis in the community. Lancet (1993) 4.96
Disseminated "Mycobacterium genavense" infection in patients with AIDS. Lancet (1992) 4.42
Genetic diversity among strains of Mycobacterium avium causing monoclonal and polyclonal bacteremia in patients with AIDS. J Infect Dis (1993) 4.23
Numerical taxonomy of mycobactin-dependent mycobacteria, emended description of Mycobacterium avium, and description of Mycobacterium avium subsp. avium subsp. nov., Mycobacterium avium subsp. paratuberculosis subsp. nov., and Mycobacterium avium subsp. silvaticum subsp. nov. Int J Syst Bacteriol (1990) 3.86
Opportunistic pathogens in the genus Mycobacterium. Annu Rev Microbiol (1985) 2.67
IS901, a new member of a widespread class of atypical insertion sequences, is associated with pathogenicity in Mycobacterium avium. Mol Microbiol (1991) 2.64
Sources of Mycobacterium avium complex infection resulting in human diseases. Am Rev Respir Dis (1977) 2.61
Mycobacterial disease, immunosuppression, and acquired immunodeficiency syndrome. Clin Microbiol Rev (1989) 2.20
Biologically distinct subtypes of Mycobacterium avium differ in possession of insertion sequence IS901. J Clin Microbiol (1992) 2.18
Mycobacterium genavense sp. nov. Int J Syst Bacteriol (1993) 1.88
Mycobacteriosis due to Mycobacterium genavense in six pet birds. J Clin Microbiol (1993) 1.49
The avian tubercle bacillus and its relatives. J Appl Bacteriol (1990) 1.45
[Comparative study of serotypes of "Mycobacterium avium" isolated from human and animal (author's transl)]. Ann Microbiol (Paris) (1980) 0.82
Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol (1993) 18.91
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet (1993) 16.75
Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis. Nat Biotechnol (1998) 6.59
Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob Agents Chemother (1994) 6.39
Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients. AIDS (2001) 5.52
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet (2000) 5.49
Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol (1997) 5.09
Molecular approach to identifying route of transmission of tuberculosis in the community. Lancet (1993) 4.96
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study. Lancet (1999) 4.83
Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis. Antimicrob Agents Chemother (1993) 4.54
Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. Arch Pathol Lab Med (1995) 4.10
Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob Agents Chemother (2000) 3.56
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA (1999) 3.34
The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat Med (1997) 3.28
A novel insertion element from Mycobacterium avium, IS1245, is a specific target for analysis of strain relatedness. J Clin Microbiol (1995) 3.20
Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study. Circulation (1999) 3.16
Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob Agents Chemother (1997) 3.05
Isolation and characterization of a unique group of slowly growing mycobacteria: description of Mycobacterium lentiflavum sp. nov. J Clin Microbiol (1996) 2.66
Crystal structure of GyrA intein from Mycobacterium xenopi reveals structural basis of protein splicing. Nat Struct Biol (1998) 2.59
Role of embB in natural and acquired resistance to ethambutol in mycobacteria. Antimicrob Agents Chemother (1997) 2.53
Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individuals. Clin Pharmacol Ther (2007) 2.48
HIV treatment failure: testing for HIV resistance in clinical practice. Science (1998) 2.46
Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J (2008) 2.43
Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. AIDS (2001) 2.42
Heterogeneity and clonality among isolates of Mycobacterium kansasii: implications for epidemiological and pathogenicity studies. J Clin Microbiol (1997) 2.24
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study. Clin Infect Dis (2001) 2.24
Mutation position and type of substitution in the beta-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis. J Antimicrob Chemother (1995) 2.22
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study. N Engl J Med (1999) 2.17
Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in Singapore. Antimicrob Agents Chemother (1999) 2.02
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet (2001) 2.01
Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation. Am J Transplant (2009) 1.88
Polymorphism of HIV type 1 gag p7/p1 and p1/p6 cleavage sites: clinical significance and implications for resistance to protease inhibitors. AIDS Res Hum Retroviruses (2000) 1.82
IS1245 restriction fragment length polymorphism typing of Mycobacterium avium isolates: proposal for standardization. J Clin Microbiol (1998) 1.80
Prospective age-matching in elderly kidney transplant recipients--a 5-year analysis of the Eurotransplant Senior Program. Am J Transplant (2007) 1.72
Development and application of real-time PCR assay for quantification of Mycobacterium ulcerans DNA. J Clin Microbiol (2003) 1.72
The association of eosinophilia with lymphoblastic leukaemia or lymphoma: a study of seven patients. Br J Haematol (1980) 1.63
CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Swiss HIV Cohort Study. Lancet (1998) 1.62
Typing of Pneumocystis carinii f. sp. hominis by single-strand conformation polymorphism of four genomic regions. J Clin Microbiol (1997) 1.59
Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity. Cancer (1998) 1.58
Pharmacogenetics-based population pharmacokinetic analysis of efavirenz in HIV-1-infected individuals. Clin Pharmacol Ther (2009) 1.57
Premature atherosclerosis in HIV-infected individuals--focus on protease inhibitor therapy. AIDS (2001) 1.55
Evaluation of the relatedness of strains of Mycobacterium avium using pulsed-field gel electrophoresis. Eur J Clin Microbiol Infect Dis (1995) 1.51
PCR detection of virulence genes in Yersinia enterocolitica and Yersinia pseudotuberculosis and investigation of virulence gene distribution. Appl Environ Microbiol (2003) 1.41
Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study. J Acquir Immune Defic Syndr (1999) 1.36
PCR detection, characterization, and distribution of virulence genes in Aeromonas spp. Appl Environ Microbiol (1999) 1.30
Emergence of canine ocular Thelaziosis caused by Thelazia callipaeda in southern Switzerland. Vet Parasitol (2008) 1.28
Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein. J Virol (2001) 1.22
Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 1.20
Evaluation of the rpoB gene in rifampicin-susceptible and -resistant Mycobacterium avium and Mycobacterium intracellulare. J Antimicrob Chemother (1994) 1.16
Molecular epidemiology of tuberculosis among HIV-infected persons in Switzerland: a countrywide 9-year cohort study. Swiss HIV Cohort Study. Infection (2000) 1.14
Invasive infection with Mycobacterium genavense in three children with the acquired immunodeficiency syndrome. Eur J Clin Microbiol Infect Dis (1993) 1.13
The decaying genome of Mycobacterium leprae. Lepr Rev (2001) 1.11
Behavior of Listeria monocytogenes during fabrication and storage of experimentally contaminated smoked salmon. Appl Environ Microbiol (1991) 1.10
A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 1.10
Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant (1999) 1.09
Influence of inhibitory killer immunoglobulin-like receptors and their HLA-C ligands on resolving hepatitis C virus infection. Tissue Antigens (2007) 1.05
Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients. J Clin Oncol (1997) 1.05
Extramedullary disease in Ph'-positive chronic myelogenous leukemia: frequency, clinical features and prognostic significance. Haematologica (1990) 1.04
More on "what's in a name ... "--pragmatism in mycobacterial taxonomy. Int J Tuberc Lung Dis (1998) 1.04
Drug resistance in Mycobacterium tuberculosis. Eur Respir J Suppl (1995) 1.04
Antiretroviral therapies from the patient's perspective. AIDS Care (2000) 1.04
Tenascin variants: differential binding to fibronectin and distinct distribution in cell cultures and tissues. Cell Regul (1991) 1.03
Development of real-time PCR for the differential detection and quantification of Ureaplasma urealyticum and Ureaplasma parvum. J Microbiol Methods (2005) 1.03
The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement. Haematologica (1998) 1.03
Nelfinavir plasma levels under twice-daily and three-times-daily regimens: high interpatient and low intrapatient variability. Ther Drug Monit (2001) 1.02
Detection of Mycobacterium avium subspecies paratuberculosis in Swiss dairy cattle by real-time PCR and culture: a comparison of the two assays. J Appl Microbiol (2005) 1.02
Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women. Epilepsia (1999) 1.02
[Rhodococcus erythropolis infection in HIV-associated immunodeficiency]. Schweiz Med Wochenschr (1991) 0.98
A major oligomeric fibroblast proteoglycan identified as a novel large form of type-XII collagen. Eur J Biochem (1992) 0.98
The evolutionary history of the CD209 (DC-SIGN) family in humans and non-human primates. Genes Immun (2008) 0.97
Typing Listeria monocytogenes isolates from fish products and human listeriosis cases. Appl Environ Microbiol (1997) 0.97
HIV-Protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases. J Invest Dermatol (1999) 0.96
Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials(†). Am J Transplant (2013) 0.96
Polymicrobial fungemia: microbiology, clinical features, and significance. Rev Infect Dis (1989) 0.95
Accidental infection of veterinary personnel with Mycobacterium tuberculosis at necropsy: a case study. Vet Microbiol (2010) 0.95
Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies. Bone Marrow Transplant (2000) 0.94
Translocation (8;16) in a patient with acute myelomonocytic leukemia, occurring after treatment with fludarabine for a low-grade non-Hodgkin's lymphoma. Haematologica (2000) 0.94
Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients. Leukemia (2003) 0.93
Successful treatment of disseminated nocardiosis complicated by cerebral abscess with ceftriaxone and amikacin: case report. Clin Infect Dis (1992) 0.93
The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders. Br J Haematol (1999) 0.93
Chronic myelomonocytic leukemia: clinical features, cytogenetics, and prognosis in 30 consecutive cases. Hematol Oncol (1985) 0.93
Candidemia from a urinary tract source: microbiological aspects and clinical significance. Clin Infect Dis (1993) 0.93
A single heparin binding region within the fibrinogen-like domain is functional in chick tenascin-C. J Biol Chem (1995) 0.93
Clinicopathologic and immunologic characteristics of non-Hodgkin's lymphomas presenting in the orbit. A report of eight cases. Cancer (1985) 0.92